WO2011002251A3 - 수태능력 예측용 마커 - Google Patents
수태능력 예측용 마커 Download PDFInfo
- Publication number
- WO2011002251A3 WO2011002251A3 PCT/KR2010/004298 KR2010004298W WO2011002251A3 WO 2011002251 A3 WO2011002251 A3 WO 2011002251A3 KR 2010004298 W KR2010004298 W KR 2010004298W WO 2011002251 A3 WO2011002251 A3 WO 2011002251A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- marker
- fertility
- predicting fertility
- predicting
- animals
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/124—Animal traits, i.e. production traits, including athletic performance or the like
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/367—Infertility, e.g. sperm disorder, ovulatory dysfunction
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Urology & Nephrology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
본 발명은 동물의 수태능력 예측용 마커, 수태능력 예측용 조성물 및 수태능력을 예측하는 방법에 관한 것이다. 보다 구체적으로는, 동물의 수태능력에 따라 달리 발현되는 마커를 발굴하고, 상기 마커에 특이적으로 결합하는 항체, 상기 마커를 암호화하는 유전자에 특이적으로 결합하는 프라이머 또는 프로브를 포함하는 조성물 및 이를 이용하여 동물의 수태 능력을 예측하는 방법에 관한 것이다.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2009-0059975 | 2009-07-01 | ||
KR20090059975 | 2009-07-01 | ||
KR10-2009-0100446 | 2009-10-21 | ||
KR1020090100446A KR101112747B1 (ko) | 2009-07-01 | 2009-10-21 | 동물 정자의 수정능력 예측용 마커 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011002251A2 WO2011002251A2 (ko) | 2011-01-06 |
WO2011002251A3 true WO2011002251A3 (ko) | 2011-05-05 |
Family
ID=43411625
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2010/004298 WO2011002251A2 (ko) | 2009-07-01 | 2010-07-01 | 수태능력 예측용 마커 |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2011002251A2 (ko) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08507530A (ja) * | 1993-03-10 | 1996-08-13 | ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア | トランスフォーミング成長因子βによる受胎能調節 |
WO2007003007A1 (en) * | 2005-07-05 | 2007-01-11 | Adelaide Fertility Centre Pty Ltd | Methods and compositions for improving pregnancy outcome |
KR20090025459A (ko) * | 2007-09-06 | 2009-03-11 | 중앙대학교 산학협력단 | 정배수성 정자의 선별법 |
-
2010
- 2010-07-01 WO PCT/KR2010/004298 patent/WO2011002251A2/ko active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08507530A (ja) * | 1993-03-10 | 1996-08-13 | ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア | トランスフォーミング成長因子βによる受胎能調節 |
WO2007003007A1 (en) * | 2005-07-05 | 2007-01-11 | Adelaide Fertility Centre Pty Ltd | Methods and compositions for improving pregnancy outcome |
KR20090025459A (ko) * | 2007-09-06 | 2009-03-11 | 중앙대학교 산학협력단 | 정배수성 정자의 선별법 |
Non-Patent Citations (2)
Title |
---|
HULUSI BULENT ZEYNELOGLU ET AL.: "Detection of chromosomal abnormalities by fluorescent in- situ hybridization in immotile viable spermatozoa determined by hypo-osmotic sperm swelling test", HUM. REPROD., vol. 15, no. 4, April 2000 (2000-04-01), pages 853 - 856 * |
SHIN-AE OH ET AL.: "Relationship between the mRNA Expression Levels of Sperm Phosphollpids Hydroperoxide Glutathione Peroxidase and Heparin-Binding Protein, and in- Vivo Fertility in Boars", REPRODUCTIVE & DEVELOPMENTAL BIOLOGY, vol. 31, no. 3, September 2007 (2007-09-01), pages 133 - 137 * |
Also Published As
Publication number | Publication date |
---|---|
WO2011002251A2 (ko) | 2011-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2262911A4 (en) | COMPOSITIONS, PROCESSES AND KITS WITH SYNTHETIC PROBES FOR DETECTING THE PRESENCE OF A TARGET NUCLEIC ACID | |
WO2010036969A3 (en) | Genetic markers for assessing risk of developing schizophrenia | |
WO2011079902A3 (en) | Biological inhibitors of ror1 capable of inducing cell death | |
WO2009113828A3 (en) | Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid | |
EA201201036A1 (ru) | Целевые геномные изменения | |
WO2009099942A3 (en) | Chemically modified oligonucleotides and uses thereof | |
WO2008154249A3 (en) | Gene expression markers of tumor resistance to her2 inhibitor treatment | |
WO2012095639A3 (en) | Methods, compositions, and kits for determing the presence/absence of a varian nucleic acid sequence | |
EP2576839A4 (en) | DETECTION AND QUANTIFICATION OF NUCLEIC ACID BY POST-HYBRIDIZED MARKING AND UNIVERSAL CODING | |
WO2009102983A3 (en) | Efficient induction of pluripotent stem cells using small molecule compounds | |
WO2008054556A3 (en) | Methods and compositions for detection of a target nucleic acid sequence | |
GB201108236D0 (en) | Method | |
AU2009209251A8 (en) | Stabilized Angiopoietin-2 antibodies and uses thereof | |
WO2009149956A3 (en) | Fusion protein and use thereof | |
WO2013003376A3 (en) | Segregating target nucleic acid from mixed nucleic acid samples | |
EP2281903A4 (en) | CANCER MARKER, METHOD FOR EVALUATING CANCER USING THE CANCER MARKER AND ASSESSING THE VALUE | |
WO2009089120A3 (en) | Genetic markers of mental illness | |
WO2009113814A3 (ko) | 간암 진단용 단백질성 마커 | |
WO2010118411A3 (en) | Improved methods for conducting assays | |
WO2011051816A3 (en) | System and method for obtaining document information | |
WO2012083969A3 (en) | Microrna for diagnosis of pancreatic cancer | |
WO2013092952A3 (de) | Verfahren zur selektiven quantifizierung von a-beta-aggregaten | |
WO2011160052A3 (en) | Methods and compositions for sequence specific rna endonucleases | |
WO2010087594A3 (ko) | 시디93 또는 이의 가용성 단편의 용도 | |
EP2075341A4 (en) | METHOD FOR THE INVESTIGATION, DETERMINATION OR EVALUATION BY MEANS OF GENE EXPRESSION ANALYSIS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10794386 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 10794386 Country of ref document: EP Kind code of ref document: A2 |